Alzheimer's: Are we on the right path to new drugs?
With the number of people living with Alzheimer's disease expected to almost triple by 2050, the race is on to find a treatment that can prevent or slow the condition. But last week saw another crack emerge in the already rocky path toward an effective Alzheimer's medication; pharmaceutical giant Eli Lilly announced the failure of what had previously been hailed a "breakthrough" in the treatment of the most common form of dementia....